Evaluation of commercially available fully automated and elisa-based assays for detecting anti-sars-cov-2 neutralizing antibodies

HIGHLIGHTS

• who: Hadeel T. Zedan from the DepartmentQatar University have published the research: Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies, in the Journal: Scientific Reports Scientific Reports of 26/09/2022

SUMMARY

Mindray Bio-Medical ­Electronics8,9,16 using three chemiluminescence immunoassays to detect anti-SARS-CoV-2 bAbs targeting either the S and N proteins or exclusively the RBD: (i) Anti-SARS-CoV-2 IgG against S/N protein (Cat. No SARS-CoV-2 IgG121) with a cutoff index of ≥ 10 IU . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.